Professional Documents
Culture Documents
Mitral Valve
Consists of 6 major anatomical components
Annulus Leaflets Chordae tendinae Papillary muscles Posterior left atrial wall Left ventricular free wall
Description Saddle Shaped, 4-6cm2 Sail shaped AML & C shaped PML Anterolateral PM at 4 O Clock, Posteromedial PM at 7 O Clock position 120 in number
Papillary
Chordea Tendinae
Epidemiology
Prevalence of 2.4% of population Twice frequent in females than in males Severe MVP occurs more frequently in older males (>50yrs)
Etiology
Primary condition
Familial Autosomal trait Non familial
Secondary conditions
Heritable disorders of connective tissue
Classification
Classification of MVP Mitral Valve Prolapse syndrome Younger age (20-50) Predominantly females Click or click murmur present Benign long term course Myxomatous Mitral Valve Disease Older age- 40-70yr Predominantly males Thickened & redundant valve leaflets Progressive disease, requires surgery Secondary Mitral Valve Prolapse Marfan syndrome Hypertrophic cardiomyopathy Ehlers-Danlos syndrome Other connective tissue disorders
Pathology
Myxomatous proliferation of mitral valve leaflets & quantity of acid mucopolysaccharide is increased. Regions of endothelial disruption are common & possible site for thrombus formation or endocarditis. Degeneration of collagen & myxomatous changes within the central core of chordae tendinae causes decrease of tensile strength & thus rupture
Clinical Diagnosis
Symptoms
Signs
Auscultation
Mid or late systolic click, heard over apex Pansystolic murmur present if associated with severe mitral regurgitation Dynamic auscultation
Change in loudness as well as the time of occurrence of both click & murmur are diagnostic
Echocardiography
Confirmatory Prolapse of mitral leaflet into left atrium Thickening of mitral valve (>5mm)
Angiography
Disease course
General outcome is excellent, large group remain asymptomatic Serious complications occur in 1/100 patient years 4% died during 8yrs Most of the risk factors were based on severity of MR , ejection fraction (<50%), left atrial dimensions (>40mm), age (>50yr) Risk of development of IE is greater in men >50yrs
Other complications
CNS
Acute hemiplegia TIAs Amaurosis fugax Cerebellar infarcts Unexplained stroke of young!
Management
Transesophageal echo in first degree should be done (Circulation 2005) Echo should confirm the diagnosis Asymptomatic patients without arrhythmias/IE should be reassured & follow up examination every 3 to 5yrs to be done (follow up with color doppler) Patients with palpitations, arrhythmias should undergo EP study to characterize arrhythmias & RF if necessary for AV bypass tracts in prolonged SVT episodes
Management
Beta blockers for palpitations secondary to PVCs & relieve chest discomfort Aspirin in documented cases of neurological event or if atrial thrombus exists (Hayek; Mitral valve prolapse. Lancet. 2005 Feb 511;365(9458):507-18)
Patients with severe MR & MVP may require MV surgical repair. Antibiotic prophylaxis for GI & GU procedures (NICE Clinical Guideline (March 2008)
Thank You !